Media Summary: Marcus Butler, MD, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses data on the Marcus Butler, MD, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses Prof. Caroline Robert (Gustave Roussy, France) presents at ASCO 2017 the results of the KEYNOTE-006 study, showing ...
Efficacy Of Pembrolizumab Treatment In Mucosal Melanoma - Detailed Analysis & Overview
Marcus Butler, MD, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses data on the Marcus Butler, MD, from the Princess Margaret Cancer Centre, Toronto, Canada, discusses Prof. Caroline Robert (Gustave Roussy, France) presents at ASCO 2017 the results of the KEYNOTE-006 study, showing ... Jason Luke, MD, FACP, UPMC Hillman Cancer Center, Pittsburgh, PA, comments on updated results from the Phase III ... Alexander M. Eggermont, MD, PhD, professor of Oncological Surgery and general director of Gustave Roussy Cancer Campus ... Karijn Suijkerbuijk, MD, PhD, UMC Utrecht, Utrecht, The Netherlands, discusses the
Georgina Long, MD, PhD, from the University of Sydney, Sydney, Australia, discusses the Jason Luke reports on key results from ESMO Congress 2021 on LBA3 - Yana Najjar, MD, UPMC Hillman Cancer Center, Pittsburgh, PA, describes the challenges in Prof Ribas presents the findings of a phase III trial, which showed Jeffrey S. Weber, MD, PhD, a medical oncologist and deputy director of the Laura and Isaac Perlmutter Cancer Center at NYU ... Website: Twitter: Facebook: LinkedIn: ...
Dr. Michael Atkins presents findings from his study on Dr Luke talks to ecancer at ASCO 2023 about a final analysis from the phase 3 KEYNOTE-716 study. This looked at distant ... Paolo Ascierto, MD, National Tumor Institute, Milan, Italy, discusses the benefits of nivolumab and relatlimab Michael Atkins, MD, from the Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, discusses promising data ...
